Mycobacterium szulgai: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) |
Shanshan Cen (talk | contribs) |
||
| Line 18: | Line 18: | ||
===Antimicrobial regimen=== | ===Antimicrobial regimen=== | ||
* in vitro | * in vitro | ||
:* Susceptible: Most anti-TB drugs | :* Susceptible: Most anti-TB drugs, [[Quinolones]], [[Macrolides]] | ||
* | |||
:* Preferred regimen: a three- to four-drug regimen that includes 12 months of negative sputum cultures while on therapy is probably adequate | |||
:* Alternative regimen: [[INH]] {{and}} [[Rifampin]] {{and}} [[Pyrazinamide]] for 6 months | |||
==References== | ==References== | ||
Revision as of 16:19, 7 July 2015
| style="background:#Template:Taxobox colour;"|Mycobacterium | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| style="background:#Template:Taxobox colour;" | Scientific classification | ||||||||||||||
|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Mycobacterium szulgai is a species of Mycobacterium. It is a Scotochromogen and is currently ungrouped. It is known to cause skin infections.[1]
Treatment
Antimicrobial regimen
- in vitro
- Susceptible: Most anti-TB drugs, Quinolones, Macrolides
- Preferred regimen: a three- to four-drug regimen that includes 12 months of negative sputum cultures while on therapy is probably adequate
- Alternative regimen: INH AND Rifampin AND Pyrazinamide for 6 months
References
- ↑ Hizawa K, Nagata Y, Kudo T, Taniguchi M, Matsumoto T, Iida M (September 2009). "[A case of steroid-dependent ulcerative colitis complicated by skin infection of Mycobacterium szulgai]". Nippon Shokakibyo Gakkai Zasshi (in Japanese). 106 (9): 1359–63. PMID 19734708.